To determine whether the dosing time-dependent anti-colitis effects of CR in mice are associated with berberine and REV-ERBα, we measured colonic MDA and MPO activities as well as IL-1β and IL-6 levels in Rev-erbα−/− mice with colitis after 7 days’ CR treatment. The gene discussed is MPO; the disease is colitis.